Ensol Biosciences Inc. announced that it expects to receive KRW 6.9999856 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm
January 08, 2021
Share
Ensol Biosciences Inc. (XKON:A140610) announced a private placement of 472,972 registered convertible preferred shares at a price of KRW 14,800 per share for gross proceeds of KRW 6,999,985,600 on January 8, 2021. The transaction will include participation from new investors Korea Investment & Securities Co., Ltd., Mirae Asset Daewoo Co., Ltd. (KOSE:A006800), NH Investment & Securities Co., Ltd. (KOSE:A005940), and Samsung Securities Co., Ltd. (KOSE:A016360). The shares will be issued at premium to par value of KRW 500 per share. Each preferred share is convertible into a common share between January 16, 2022 and January 15, 2031. The preferred shares bear 1% per annum cumulative and participative dividend. The preferred shares are subject to 1 year hold period. The expected payment date is January 15, 2021 and expected issue date is February 02, 2021. The transaction is approved by the board of directors of the company.
Ensol Biosciences Inc. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved in the development and sale of drugs for degenerative disc disease (DDD), osteoarthritis, triple negative breast cancer (TNBC), Alzheimer's disease (AD) and type I diabetes. In addition, it also produces and sells drugs for animal and provides bio big data analysis services. The drugs for Animal include drugs for animal osteoarthritis, as well as animal anticancer, among others. The bio big data analysis services are provided by knowledge-based in silico drug discovery (KISDD) platform and Ensol trans-omics network system (ETONS).
Ensol Biosciences Inc. announced that it expects to receive KRW 6.9999856 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm